首页> 外文期刊>Journal of biomedical materials research, Part A >Decellularized extracellular matrix derived from human adipose tissue as a potential scaffold for allograft tissue engineering.
【24h】

Decellularized extracellular matrix derived from human adipose tissue as a potential scaffold for allograft tissue engineering.

机译:脱叶细胞外基质衍生自人脂肪组织作为同种异体包装组织工程的潜在支架。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Decellularized tissues composed of extracellular matrix (ECM) have been clinically used to support the regeneration of various human tissues and organs. Most decellularized tissues so far have been derived from animals or cadavers. Therefore, despite the many advantages of decellularized tissue, there are concerns about the potential for immunogenicity and the possible presence of infectious agents. Herein, we present a biomaterial composed of ECM derived from human adipose tissue, the most prevalent, expendable, and safely harvested tissue in the human body. The ECM was extracted by successive physical, chemical, and enzymatic treatments of human adipose tissue isolated by liposuction. Cellular components including nucleic acids were effectively removed without significant disruption of the morphology or structure of the ECM. Major ECM components were quantified, including acid/pepsin-soluble collagen, sulfated glycosaminoglycan (GAG), and soluble elastin. In an in vivo experiment using mice, the decellularized ECM graft exhibited good compatibility to surrounding tissues. Overall results suggest that the decellularized ECM containing biological and chemical cues of native human ECM could be an ideal scaffold material not only for autologous but also for allograft tissue engineering.
机译:由细胞外基质(ECM)组成的脱细胞组织已被临床上用于支持各种人组织和器官的再生。到目前为止,大多数脱细胞组织是来自动物或尸体。因此,尽管脱细胞组织的许多优点,但涉及免疫原性的潜力和传染性药剂的可能存在。在此,我们介绍了由人体脂肪组织的ECM,最普遍,消耗和安全收获的组织中的ECM组成的生物材料。 ECM通过脂质分离的人类脂肪组织的连续物理,化学和酶促治疗提取。有效地去除包括核酸的细胞组分,而不会严重破坏ECM的形态或结构。量化了主要的ECM组分,包括酸/胃蛋白可溶性胶原蛋白,硫酸化糖胺聚糖(GAG)和可溶性弹性蛋白。在使用小鼠的体内实验中,脱细胞的ECM移植物对周围组织表现出良好的相容性。总体结果表明,天然人类ECM的含有生物和化学线索的脱细胞化学质检程序可能是一个理想的支架材料,不仅适用于自体,还可以是同种异体移植组织工程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号